Product Information
GABAPENTIN 100 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0210 per EA under NDC 16571086710. Its NADAC has been published 57 times since May 28, 2025.
Strength
100 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571086710
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207099On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 100 MG CAPSULE has been published 57 times since May 28, 2025, and over the history we have for it it has declined 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0210 per EA |
|---|---|
| All-time high | $0.0225 (Jun 11, 2025) |
| All-time low | $0.0210 (Jun 17, 2026) |
| 52-week high | $0.0223 |
| 52-week low | $0.0210 |
| Median price | $0.0212 |
| Average price | $0.0215 |
| Largest weekly change | -2.4% (Oct 22, 2025) |
| Weeks tracked | 57 |
| Tracking since | May 28, 2025 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0210 per EA (NDC 16571086710), effective Jun 24, 2026.
How has the price of GABAPENTIN 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 6.8%. It has been tracked across 57 weekly CMS publications since May 28, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?
Since May 28, 2025, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0210 (Jun 17, 2026) to a high of $0.0225 (Jun 11, 2025), with a median of $0.0212 per EA.
Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?
8 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 100 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 100 MG CAPSULE?
GABAPENTIN 100 MG CAPSULE (NDC 16571086710) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification